A detailed history of Bruce G. Allen Investments, LLC transactions in Organon & Co. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 160 shares of OGN stock, worth $2,579. This represents 0.0% of its overall portfolio holdings.

Number of Shares
160
Previous 141 13.48%
Holding current value
$2,579
Previous $2.92 Million 4.86%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$18.65 - $23.03 $354 - $437
19 Added 13.48%
160 $3.06 Million
Q2 2024

Jul 12, 2024

BUY
$17.45 - $21.96 $628 - $790
36 Added 34.29%
141 $2.92 Million
Q1 2024

Apr 10, 2024

SELL
$13.78 - $18.8 $2,053 - $2,801
-149 Reduced 58.66%
105 $1.97 Million
Q4 2023

Jan 10, 2024

BUY
$10.95 - $17.32 $2,781 - $4,399
254 New
254 $3.66 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.1B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.